Trademark Overview
On Monday, November 10, 2025, a trademark application was filed for UPCLIXIOR with the United States Patent and Trademark Office. The USPTO has given the UPCLIXIOR trademark a serial number of 99488513. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, November 10, 2025. This trademark is owned by Bristol- Myers Squibb Company. The UPCLIXIOR trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants;; Pharmaceutical preparations for the treatment and prevention of Stem cells for medical purposes;; Pharmaceutical preparations for the treatment and prevention of Radiopharmaceutical preparations for the treatment of cancer and solid tumors;; Pharmaceutical preparations for the treatment and prevention of Diagnostic radiopharmaceutical preparations;; Pharmaceutical preparations for the treatment and prevention of Diagnostic preparations for m...
